Market Alert: U.S.–China Trade Truce and Federal Reserve Rate Cut Bolster Investor Sentiment

The Calmer Co Achieves Record AU$344,000 Coles Sales in July 2025

Aug 06, 2025

The Calmer Co. International Limited (ASX: CCO), a leading natural wellness and kava-focused consumer goods company, has reported a record 81% increase in Coles retail sales in July 2025, reaching AU$344,000, up from AU$190,000 in June. This marks the company’s highest monthly sales result in Coles to date and exceeds its materiality threshold of 30%, highlighting the growing consumer demand for its relaxation beverages and functional kava powders.

An expanded store footprint, strong sell-through rates, and the success of targeted in-store promotions drove the sales surge. Taki Mai® Kava Shot 50mL is now available in 797 stores (+59% from launch), while Fiji Kava® Instant Kava 150g is ranged in 801 stores (+170% from launch). Founder and CEO Zane Yoshida stated that the milestone validates the company’s strategy to establish kava as a mainstream alcohol alternative, strengthen its national distribution platform, and drive scalable, sustainable revenue growth in Australia’s relaxation and wellness market.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com